Home  /  Resource Library  /  Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia treated with venetoclax: a multicenter retrospective analysis

Study investigated outcomes of patients with Waldenstrom Macroglobulinemia treated with venetoclax.